Filing search / Pulmatrix, Inc. / "Attrition"

Search information

Pulmatrix, Inc.

Companies

"Attrition"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

21 results

Newest first Best match first

of attrition for drug candidates in preclinical and clinical trials due to scientific feasibility, safety, efficacy, changing standards of medical care

28 Mar 24

9:21am

. Typically, there is a high rate of attrition for drug candidates in preclinical and clinical trials due to scientific feasibility, safety, efficacy

30 Mar 23

9:20am

at any stage of preclinical and clinical development. Typically, there is a high rate of attrition for drug candidates in preclinical and clinical

29 Mar 22

9:20am

and clinical development. Typically, there is a high rate of attrition for drug candidates in preclinical and clinical trials due to scientific feasibility

23 Mar 21

9:20am

and clinical development. Typically, there is a high rate of attrition for drug candidates in preclinical and clinical trials due to scientific

26 Mar 20

9:22am

424B4

anbw0haq

5 Apr 19

Prospectus supplement with pricing info

1 Apr 19

5:16pm

S-1/A

a167w

IPO registration (amended)

1 Apr 19

5:02pm

S-1

d2ag01qvlqul4keh

IPO registration

19 Mar 19

6:50pm

10-K

rct5cv y088d2d

Annual report

19 Feb 19

9:25am

424B5

whlaqn

11 Feb 19

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

28 Dec 18

4:52pm

424B5

xjr99q4q

3 Dec 18

Prospectus supplement for primary offering

Prospectus supplement with pricing info

13 Mar 18

12:00am

10-K

jas 9uece94

Annual report

10 Mar 17

12:00am

Filing search / Pulmatrix, Inc. / "Attrition"

21 results

Top filers

Top filing types

Recent filing years